Dreger P - Search Results

1

Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometry.

Mürdter TE, Coller J, Claviez A, Schönberger F, Hofmann U, Dreger P, Schwab M. Mürdter TE, et al. Among authors: dreger p. Clin Chem. 2001 Aug;47(8):1437-42. Clin Chem. 2001. PMID: 11468234 Clinical Trial.

2

Elevated blood drug levels obtained from indwelling silicon catheters during oral cyclosporine A administration.

Claviez A, Glass B, Dreger P, Suttorp M. Claviez A, et al. Among authors: dreger p. Bone Marrow Transplant. 2002 Mar;29(6):535-6. doi: 10.1038/sj.bmt.1703399. Bone Marrow Transplant. 2002. PMID: 11960277

3

Amplification of a Y-chromosomal DNA sequence by the polymerase chain reaction for documentation of residual recipient cells in small samples from bone marrow, peripheral blood and cerebrospinal fluid after bone marrow transplantation.

Suttorp M, Sprenger C, Dreger P, Sievers E, Claviez A, Löffler H, Schaub J, Schmitz N. Suttorp M, et al. Among authors: dreger p. Electrophoresis. 1993 Mar;14(3):174-8. doi: 10.1002/elps.1150140129. Electrophoresis. 1993. PMID: 8486127

4

Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease.

Claviez A, Klingebiel T, Beyer J, Nürnberger W, Ehninger G, Suttorp M, Dreger P, Dörffel W, Schmitz N. Claviez A, et al. Among authors: dreger p. Ann Hematol. 2004 Apr;83(4):237-41. doi: 10.1007/s00277-003-0814-y. Epub 2003 Nov 19. Ann Hematol. 2004. PMID: 14625790

5

Epstein-Barr virus-associated post-transplant lymphoproliferative disease after bone marrow transplantation mimicking graft-versus-host disease.

Claviez A, Tiemann M, Wagner HJ, Dreger P, Suttorp M. Claviez A, et al. Among authors: dreger p. Pediatr Transplant. 2000 May;4(2):151-5. doi: 10.1034/j.1399-3046.2000.00108.x. Pediatr Transplant. 2000. PMID: 11272609

6

Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effect.

Glass B, Nickelsen M, Dreger P, Claviez A, Hasenkamp J, Wulf G, Trümper L, Schmitz N. Glass B, et al. Among authors: dreger p. Bone Marrow Transplant. 2004 Sep;34(5):391-7. doi: 10.1038/sj.bmt.1704600. Bone Marrow Transplant. 2004. PMID: 15273707 Clinical Trial.

7

Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT.

Dreger P, Glass B, Seyfarth B, Humpe A, Claviez A, von Neuhoff N, Suttorp M, Schoch R, Schmitz N. Dreger P, et al. Bone Marrow Transplant. 2000 Dec;26(12):1361-2. doi: 10.1038/sj.bmt.1702722. Bone Marrow Transplant. 2000. PMID: 11223980 No abstract available.

8

High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease.

Schmitz N, Glass B, Dreger P, Haferlach T, Horst HA, Ollech-Chwoyka J, Suttorp M, Gassmann W, Löffler H. Schmitz N, et al. Among authors: dreger p. Ann Hematol. 1993 May;66(5):251-6. doi: 10.1007/BF01738475. Ann Hematol. 1993. PMID: 8099502

9

Allogeneic transplantation of peripheral blood stem cells.

Dreger P, Schmitz N. Dreger P, et al. Baillieres Best Pract Res Clin Haematol. 1999 Mar-Jun;12(1-2):261-78. doi: 10.1053/beha.1999.0022. Baillieres Best Pract Res Clin Haematol. 1999. PMID: 11000998 Review.

10

Allogeneic transplantation of blood stem cells: coming of age?

Dreger P, Schmitz N. Dreger P, et al. Ann Hematol. 2001 Mar;80(3):127-36. doi: 10.1007/s002770000279. Ann Hematol. 2001. PMID: 11320896 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters